Advanced Filter

Filter by Group

Filter by Market Availability

Did you mean 2,3 10 3?
Displaying drugs 9651 - 9675 of 11731 in total
Investigational
Selatogrel is under investigation in clinical trial NCT03814200 (A Study to Investigate the Effect of Rifampicin on the Uptake and Breakdown of ACT-246475 in Healthy Subjects).
Investigational
Matched Iupac: … [(2R)-3-[4-(butoxycarbonyl)piperazin-1-yl]-2-({6-[(3S)-3-methoxypyrrolidin-1-yl]-2-phenylpyrimidin-4- ... yl}formamido)-3-oxopropyl]phosphonic acid …
Investigational
Matched Synonyms: … 2-methylpropionamide …
Matched Iupac: … 2-methylpropanamide …
Hydroxypropyl betadex is under investigation in clinical trial NCT03471143 (Study of IV VTS-270 for Infantile Liver Disease Associated With Niemann-Pick Disease, Type C).
Investigational
Matched Synonyms: … 2-Hydroxypropyl-b-cyclodextrin ... 2-Hydroxylpropyl-beta-cyclodextrin ... 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN …
Matched Iupac: … [31.2.2.2^{3,6}.2^{8,11}.2^{13,16}.2^{18,21}.2^{23,26}.2^{28,31}]nonatetracontane-36,37,38,39,41,42,43,45,46,48 ... 36R,37R,38R,39R,40R,41R,42R,43R,45R,46S,47R,48S,49R)-5,10,25,35-tetrakis(hydroxymethyl)-40,47,49-tris(2- ... hydroxypropoxy)-15,20,30-tris[(2-hydroxypropoxy)methyl]-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo …
Investigational
Ecromeximab has been used in trials studying the treatment of Cutaneous Melanoma and Metastatic Melanoma.
Investigational
Avizakimab is under investigation in clinical trial NCT03371251 (Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care).
Investigational
Experimental
Matched Name: … 2-amino-8-methyl-4(1H)-quinazolinone …
Matched Iupac: … 2-amino-8-methyl-1,4-dihydroquinazolin-4-one …
9-(4-hydroxybutyl)-N2-phenylguanine is a solid. This compound belongs to the hypoxanthines. These are compounds containing the purine derivative 1H-purin-6(9H)-one. 9-(4-hydroxybutyl)-n2-phenylguanine is known to target thymidine kinase.
Experimental
Matched Iupac: … 9-(4-hydroxybutyl)-2-(phenylamino)-6,9-dihydro-1H-purin-6-one …
Experimental
Matched Name: … 2-Dimethylamino-Ethyl-Diphosphate …
Matched Iupac: … ({[2-(dimethylamino)ethoxy](hydroxy)phosphoryl}oxy)phosphonic acid …
Experimental
Matched Name: … (R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol …
Matched Iupac: … (1R)-2-azido-1-(4-nitrophenyl)ethan-1-ol …
Tralesinidase alfa is a chimeric fusion protein comprised of recombinant human NAGLU and a modified human insulin-like growth factor 2. It is being investigated for the treatment of mucopolysaccharidosis type IIIB (MPS IIIB), also known as Sanfilippo syndrome B.
Investigational
Matched Synonyms: … Alpha-N-acetyglucosaminidase-insulin-like-growth-factor-2 fusion protein ... Recombinant human alpha-N-acetylglucosaminidase-insulin-like growth factor-2
Matched Description: … fusion protein comprised of recombinant human NAGLU and a modified human insulin-like growth factor 2. …
Experimental
Matched Name: … 6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide …
Matched Iupac: … N-[4-(aminomethyl)phenyl]-6-carbamimidoyl-4-[(pyrimidin-2-yl)amino]naphthalene-2-carboxamide …
Experimental
Matched Synonyms: … (S)-2-Hydroxy-2-phenylacetic acid …
Matched Iupac: … (2S)-2-hydroxy-2-phenylacetic acid …
Recombinant human relaxin is a hormone produced during pregnancy that facilitates the birth process by causing a softening and lengthening of the cervix and the pubic symphysis (the place where the pubic bones come together).It is a heterodimer protein secreted by the corpus luteum and placenta during pregnancy.
Investigational
Matched Synonyms: … Human relaxin 2 (relaxin h2) …
R-roscovitine (Seliciclib or CYC202) is a cyclin-dependent kinase (CDK) inhibitor that preferentially inhibits multiple enzyme targets including CDK2, CDK7 and CDK9, which alter the growth phase of treated cells. Developed by Cyclacel, seliciclib is being researched for the treatment of non-small cell lung cancer (NSCLC), leukemia, HIV infection, herpes simplex...
Investigational
Matched Synonyms: … 2-(R)-(1-ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine …
Matched Iupac: … (2R)-2-{[6-(benzylamino)-9-(propan-2-yl)-9H-purin-2-yl]amino}butan-1-ol …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Experimental
Matched Name: … 1-(4-thiophen-2-ylphenyl)methanamine …
Matched Iupac: … 1-[4-(thiophen-2-yl)phenyl]methanamine …
Experimental
Matched Synonyms: … Salicylic acid, methyl ester, 2-ethylbutyrate …
Matched Name: … Methyl salicylate 2-ethylbutyrate …
Matched Iupac: … methyl 2-[(2-ethylbutanoyl)oxy]benzoate …
Experimental
Matched Name: … (R)-N-methyl-N-2-propynyl-1-indanamine …
Matched Iupac: … (1R)-N-methyl-N-(prop-2-yn-1-yl)-2,3-dihydro-1H-inden-1-amine …
Experimental
Matched Name: … Benzo[B]Thiophene-2-Carboxamidine …
Matched Iupac: … [amino(1-benzothiophen-2-yl)methylidene]azanium …
Experimental
Matched Name: … 4-(2-AMINOPHENYL)-4-OXOBUTANOIC ACID …
Matched Iupac: … 4-(2-aminophenyl)-4-oxobutanoic acid …
MDI-P has demonstrated potent anti-HIV activity. MDI-P has been shown to be effective in killing HIV in cell culture. HIV is the virus that causes acquired immune deficiency syndrome (AIDS). MDI-P is also a potential therapeutic agent for the treatment of the symptoms of cystic fibrosis ("CF").
Investigational
Matched Iupac: … [1-(2H-1,3-benzodioxol-5-yl)propan-2-yl](propan-2-yl)amine …
Experimental
Matched Iupac: … ,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl]-2-oxoethyl acetate ... 2-[(1R,2S,3aS,3bS,9aR,9bS,11aS)-1-hydroxy-2,9a,11a-trimethyl-7,10-dioxo-1H,2H,3H,3aH,3bH,4H,5H,7H,9aH …
Experimental
Matched Name: … Uridine-5'-diphosphate-4-deoxy-4-fluoro-alpha-D-galactose …
Matched Iupac: … {[(2R,3S,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}[({[( ... 2R,3R,4R,5S,6R)-5-fluoro-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}(hydroxy)phosphoryl)oxy]phosphinic …
Experimental
Matched Iupac: … (2S)-3-[4-({[5-(dimethylamino)naphthalen-1-yl]sulfonyl}oxy)phenyl]-2-[5-(dimethylamino)naphthalene-1- …
Displaying drugs 9651 - 9675 of 11731 in total